Skip to main content
Elsevier

Inflammation and Cancer

Mechanisms, Diagnosis, and Therapeutic Strategies

  • 1st Edition - April 22, 2026
  • Latest edition
  • Editors: Anoop Kumar, Neeraj Mishra, Arun Kumar Singh, Ashutosh Pareek, Pranav Kumar Prabhakar
  • Language: English

Inflammation and Cancer: Mechanisms, Diagnosis, and Therapeutic Strategies delves into the intricate relationship between inflammation and cancer, a crucial area of contem… Read more

Back to School

Start strong. Study with purpose.

Save up to 25% on trusted learning resources

Shop now

Description

Inflammation and Cancer: Mechanisms, Diagnosis, and Therapeutic Strategies delves into the intricate relationship between inflammation and cancer, a crucial area of contemporary biomedical research. Sections provide an overview of inflammation's role in cancer, discussing molecular connections and signaling pathways. Chapters explore inflammatory pathways in various cancers, including breast, oral, lung, prostate, skin, and gastrointestinal cancers. The book also covers tumorigenesis, metastasis, preventive strategies, inflammatory biomarkers for cancer diagnosis, and innovative therapeutic designs. Final chapters focus on the dual role of platelets, targeting tumor-associated macrophages, novel treatment approaches, and recent advances in the field.

This title offers substantial benefits to researchers, clinicians, and healthcare professionals by providing a thorough understanding of the cellular and molecular pathways linking inflammation and cancer, aiding in the development of effective anti-cancer immunotherapies. By highlighting the latest research and potential therapeutic strategies, this book serves as an essential resource for anyone dedicated to combating cancer through innovative and informed immunotherapeutic approaches.

Key features

  • Explores the intricate relationship between inflammation and cancer, tumor initiation, and progression
  • Provides a comprehensive analyses of inflammatory pathways in various cancers
  • Offers insights into molecular mechanisms and the inflammatory signaling pathways crucial for developing effective anti-cancer therapies
  • Highlights innovative immunotherapeutic strategies and preventive measures to more effectively target cancer
  • Conveys the latest research advancements and future directions in cancer-related inflammation studies

Readership

Research Scholars and clinicians in immunology and cancer fields. Graduate, Post-Graduate Students in immunology and cancer fields.

Table of contents

1. Inflammation's Role in Cancer: Unveiling the Molecular Connections

2. Inflammatory Pathways in Breast Cancer Development

3. Inflammatory Pathways in Oral Cancer Development

4. Inflammatory Pathways in Lung Cancer Development

5. Inflammatory Pathways in Prostate Cancer Development

6. Inflammatory Pathways in Skin Cancer Development

7. Inflammatory Pathways in Development of GIT Related Cancers

8. From Inflammation to Invasion: Understanding Tumorigenesis and Metastasis

9. Preventive Strategies and Public Health Implications for Management of Cancer and Inflammation

10. Inflammatory Biomarkers for Cancer Diagnosis

11. Unraveling Inflammation's Role in Tumorigenesis: Toward Rational Anti-Cancer Therapeutic Design

12. Unraveling Platelets' Dual Role: Bridging Inflammation and Cancer Toward Innovative Therapeutic Strategies

13. Targeting Tumor-Associated Macrophages: Novel Therapeutic Strategies and Future Directions in Cancer Treatment

14. A New Approach to Cancer Treatment: Reducing Inflammation

15. Recent Advances, Current Challenges and Future Perspectives

Product details

  • Edition: 1
  • Latest edition
  • Published: April 22, 2026
  • Language: English

About the editors

AK

Anoop Kumar

Dr. Anoop Kumar is an Assistant Professor in the Department of Pharmacology at Delhi Pharmaceutical Sciences & Research University (DPSRU), India. With a distinguished career, he has previously served as an Assistant Professor and Head at the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, and as Head and Associate Professor at ISF College of Pharmacy, Moga, Punjab. Dr. Kumar has also held research positions at Sun Pharmaceutical Industries Limited and Translational Health Science Institute (THSTI). He earned his Ph.D. from Birla Institute of Technology, Mesra, Ranchi, as a DST INSPIRE Fellow. He is an Associate Editor for Health Sciences Review and Acta Neurologica Scandinavica. His research focuses on drug repurposing, clinical trial meta-analysis, pharmacoeconomics, and pharmacovigilance.

Affiliations and expertise
Assistant Professor, Delhi Pharmaceutical Sciences and Research University (DPSRU), India

NM

Neeraj Mishra

Dr. Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Gwalior. He has over 20 years of teaching and research experience in pharmaceutics, with particular expertise in novel drug delivery systems, localized and targeted drug delivery, and nanocarrier-based therapeutics for disease. His formulations and controlled delivery approaches are aimed at improving therapeutic outcomes. Dr. Mishra has supervised postgraduate and doctoral research scholars, has contributed widely to academic literature through research publications, books, and book chapters with leading international publishers. He has won several awards including Outstanding Scientist Award, and Distinguished Professor Award. He is associated with innovation in pharmaceutical sciences through patented research contributions. Over the course of his career, he has received several academic and scientific recognitions for his contributions to teaching, and research. He has been recognized internationally for his research impact and scholarly contributions.

Affiliations and expertise
Professor and Head of Department, Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Gwalior, Madhya Pradesh, India

AS

Arun Kumar Singh

Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies.
Affiliations and expertise
Assistant Professor, University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, Tehsil Kharar, Distt. Mohali, Punjab, India

AP

Ashutosh Pareek

Ashutosh Pareek is Professor at Banasthali Vidyapith, India, with expertise in neuropharmacology and advanced drug delivery systems. His research focuses on therapeutic strategies for neurodegenerative disorders, cancer, autoimmune diseases, and related health conditions, with particular interest in the development of innovative drug delivery approaches for bioactive and immunomodulatory compounds. Dr. Pareek leads research initiatives in these areas and collaborates with national and international funding agencies on projects that advance pharmaceutical science and translational research. He has contributed extensively to the scientific literature through scholarly publications, books, patents, and research mentorship. In addition, he serves on editorial and peer-review activities for international journals in pharmacology and oncology, supporting the dissemination and evaluation of research across the biomedical sciences.

Affiliations and expertise
Professor, Department of Pharmacy, Banasthali Vidyapith, Banasthali, Tonk, Rajasthan, India

PP

Pranav Kumar Prabhakar

Dr. Pranav Kumar Prabhakar is Professor and Head of the Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, India. His research focuses on elucidating molecular mechanisms involved in metabolic disorders, particularly diabetes, including strategies for oral insulin delivery and the use of natural products to mimic signaling pathways. He is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society. Dr. Prabhakar serves on the editorial boards of, and acts as a reviewer for, several national and international scientific journals. He has published extensively in his field and has contributed to numerous books and book chapters. He has also presented his research at scientific meetings and conferences.

Affiliations and expertise
Professor and Head, Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, India

View book on ScienceDirect

Read Inflammation and Cancer on ScienceDirect